| Name | Title | Contact Details |
|---|---|---|
Rahul Yadav |
Chief Technology and Digital Officer | Profile |
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Emmis Interactive is a Chicago, IL-based company in the Software and Internet sector.
Zillion`s highly configurable, cloud platform offers a broad suite of applications and functionality used to deliver a range of consumer engagement programs. The company is headquartered in Norwalk, Connecticut, with offices in Boston.
Proliant provides clients with powerful People Tools to simplify their Payroll and HR and delight their employees. Learn how to prepare for the #PeopleFirst Economy.
With a unique Platform Approach to AI implementation, Blackstraw custom-delivers enterprise-grade AI solutions that impact business outcomes fast.